State of Alaska Department of Revenue Trims Stake in DENTSPLY SIRONA Inc (XRAY)
State of Alaska Department of Revenue trimmed its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 5.2% in the first quarter, HoldingsChannel.com reports. The fund owned 64,745 shares of the medical instruments supplier’s stock after selling 3,569 shares during the period. State of Alaska Department of Revenue’s holdings in DENTSPLY SIRONA were worth $3,209,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of XRAY. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Private Capital Group LLC lifted its position in shares of DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 359 shares during the period. Pinnacle Bank acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Truehand Inc acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $27,000. Finally, Enlightenment Research LLC acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $30,000. Institutional investors own 96.30% of the company’s stock.
Several research analysts recently issued reports on XRAY shares. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 price objective for the company in a research report on Saturday, March 9th. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, March 22nd. UBS Group lifted their price objective on DENTSPLY SIRONA from $42.00 to $53.00 and gave the stock a “neutral” rating in a research report on Tuesday, March 12th. HC Wainwright restated a “neutral” rating and set a $49.00 price objective (up from $40.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 4th. Finally, Barclays restated a “hold” rating and set a $39.00 price objective on shares of DENTSPLY SIRONA in a research report on Sunday, January 6th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $52.12.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.04. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the company earned $0.82 EPS. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. As a group, sell-side analysts expect that DENTSPLY SIRONA Inc will post 2.31 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a dividend of $0.087 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.68%. DENTSPLY SIRONA’s dividend payout ratio is presently 17.41%.
COPYRIGHT VIOLATION NOTICE: “State of Alaska Department of Revenue Trims Stake in DENTSPLY SIRONA Inc (XRAY)” was originally published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.dailypolitical.com/2019/04/15/state-of-alaska-department-of-revenue-trims-stake-in-dentsply-sirona-inc-xray.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: What is Net Asset Value (NAV)?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.